Presentation on theme: "Bioactivity of Nisin-Loaded Pluronic Microspheres Challenged by Blood Proteins Julie Auxier Dr. Joseph McGuire - Bioengineering Oregon State University."— Presentation transcript:
Bioactivity of Nisin-Loaded Pluronic Microspheres Challenged by Blood Proteins Julie Auxier Dr. Joseph McGuire - Bioengineering Oregon State University HHMI Summer 2008
Infected Hospitals Infections are the 4th largest killer in US In the US in 2005 there were: ▫94,360 invasive MRSA infections ▫18,650 associated deaths Costs millions annually Healthcare-Associated Community-Associated Source: ABCs Population-based surveillance System, Klevens et al. JAMA 2007 MRSA Infections in 2005
Infected Hospitals Problems from implanted devices: ▫Clotting ▫Bacterial adhesion ▫Proliferation Treat with heparin and other anticoagulants ▫Risk of platelet depletion, excessive bleeding
Blood Proteins Albumin, globulin, fibrinogen Fibrinogen key in coagulation Intrinsic Pathway Extrinsic Pathway Tissue Damage Tissue Factor III Factor VII Tissue Factor Complex Clotting Factor VII Activated Proenzymes, usually Factor XIII Platelet Factor PF-3 Clotting Factors VIII, IX Factor X Activator Complex Ca 2+ Fibrinogen Fibrin Prothrombin Thrombin Factor X Prothrombinase Common Pathway
Purpose Challenge Nisin-loaded F108 silica microspheres with blood proteins to quantify protein adsorption to the brush layer.
Predictions Microspheres treated with irradiated F-108 will deflect protein adsorption throughout the entire trial; however, the efficacy of nisin treated samples will decline with time.
Efficacy Test: Silanize bare silica microspheres (~1μm in diameter) Covalently bond F108 by γ irradiation Plate samples with diluted Pediococcus pentosaceus Add nisin Challenge with blood proteins Quantify with colony counting
Silanized Silica Microspheres Horse PlasmaNisin γ F108 Nisin Horse Plasma No Nisin Horse Plasma M MNMFMFN MSMNS MFSMFNS
Effect of Nisin on Pediococcus PED MN MFN MFNS MNS